5,969
Views
3,792
CrossRef citations to date
0
Altmetric
Research Article

El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis

, , &
Pages 293-299 | Published online: 10 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (200)

Jaime Raymond, Reshma Punjani, Theodore Larson, James D. Berry, D. Kevin Horton & Paul Mehta. (2023) Comparing Amyotrophic lateral sclerosis (ALS) patient characteristics from the National ALS Registry and the Massachusetts ALS Registry, data through 2015. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:7-8, pages 687-694.
Read now
Alex Berger, Matteo Locatelli, Ximena Arcila-Londono, Ghazala Hayat, Nicholas Olney, James Wymer, Kelly Gwathmey, Christian Lunetta, Terry Heiman-Patterson, Senda Ajroud-Driss, Eric A. Macklin, Marie-Abèle Bind, Kimberly Goslin, Tamela Stuchiner, Lauren Brown, Tracy Bazan, Tyler Regan, Ashley Adamo, Valerie Ferment, Carly Schroeder, Megan Somers, Georgios Manousakis, Kenneth Faulconer, Ervin Sinani, Julia Mirochnick, Hong Yu, Alexander V. Sherman & David Walk. (2023) The natural history of ALS: Baseline characteristics from a multicenter clinical cohort. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:7-8, pages 625-633.
Read now
Eva M. J. de Boer, Koen C. Demaegd, Charlotte I. de Bie, Jan H. Veldink, Leonard H. van den Berg & Michael A. van Es. (2023) Familial motor neuron disease: co-occurrence of PLS and ALS (-FTD). Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 0:0, pages 1-8.
Read now
Jeremy M. Shefner, Ammar Al-Chalabi, Jinsy A. Andrews, Adriano Chio, Mamede De Carvalho, Bettina M. Cockroft, Philippe Corcia, Philippe Couratier, Merit E. Cudkowicz, Angela Genge, Orla Hardiman, Terry Heiman-Patterson, Robert D. Henderson, Caroline Ingre, Carlayne E. Jackson, Wendy Johnston, Noah Lechtzin, Albert Ludolph, Nicholas J. Maragakis, Timothy M. Miller, Jesus S. Mora Pardina, Susanne Petri, Zachary Simmons, Leonard H. Van Den Berg, Lorne Zinman, Stuart Kupfer, Fady I. Malik, Lisa Meng, Tyrell J. Simkins, Jenny Wei, Andrew A. Wolff & Stacy A. Rudnicki. (2023) COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of success. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:5-6, pages 523-534.
Read now
Elisa Canu, Veronica Castelnovo, Paola MV Rancoita, Michela Leocadi, Alessandra Lamanuzzi, Edoardo Gioele Spinelli, Silvia Basaia, Nilo Riva, Barbara Poletti, Federica Solca, Federico Verde, Nicola Ticozzi, Vincenzo Silani, Sharon Abrahams, Massimo Filippi & Federica Agosta. (2023) Italian reference values and brain correlates of verbal fluency index – vs standard verbal fluency test – to assess executive dysfunction in ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:5-6, pages 457-465.
Read now
Rüstem Yilmaz, Torsten Grehl, Lukas Eckrich, Ines Marschalkowski, Kanchi Weishaupt, Ivan Valkadinov, Melita Simic, David Brenner, Peter M. Andersen, Joachim Wolf & Jochen H. Weishaupt. (2023) Frequency of C9orf72 and SOD1 mutations in 302 sporadic ALS patients from three German ALS centers. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:5-6, pages 414-419.
Read now
Hannah P. Rowe, Kaila L. Stipancic, Thomas F. Campbell, Yana Yunusova & Jordan R. Green. (2023) The association between longitudinal declines in speech sound accuracy and speech intelligibility in speakers with amyotrophic lateral sclerosis. Clinical Linguistics & Phonetics 0:0, pages 1-22.
Read now
Vincenzo Pierri, Giuseppe Borghero, Francesca Pili, Tommaso Ercoli, Angelo Fabio Gigante, Luigi Isaia Lecca, Rosario Vasta, Marcello Campagna, Adriano Chiò & Giovanni Defazio. (2023) Impact of occupational categories on the incidence of amyotrophic lateral sclerosis in Sardinia Island, Italy. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:3-4, pages 212-218.
Read now
Francesca Notturno, Pierpaolo Croce, Raffaele Ornello, Simona Sacco & Filippo Zappasodi. (2023) Yield of EEG features as markers of disease severity in amyotrophic lateral sclerosis: a pilot study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:3-4, pages 295-303.
Read now
Angela Genge & Adriano Chio. (2023) The future of ALS diagnosis and staging: where do we go from here?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:3-4, pages 165-174.
Read now
Anna Maksymowicz-Śliwińska, Dorothée Lulé, Krzysztof NieporĘcki, Katarzyna Ciećwierska, Albert C. Ludolph & Magdalena Kuźma-Kozakiewicz. (2023) The quality of life and depression in primary caregivers of patients with amyotrophic lateral sclerosis is affected by patient-related and culture-specific conditions. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:3-4, pages 317-326.
Read now
Paul Mehta, Jaime Raymond, Moon Han, Reshma Punjani, Theodore Larson, James D. Berry, Benjamin Rix Brooks, Björn Oskarsson, Stephen a. Goutman & Kevin Horton. (2023) A revision to the United States national ALS registry’s algorithm to improve Case-Ascertainment. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:3-4, pages 230-236.
Read now
Mira Ahmad, Shelagh K. Genuis, Westerly Luth, Tania Bubela & Wendy S. Johnston. (2023) Amyotrophic lateral sclerosis (ALS) health charities are central to ALS care: perspectives of Canadians affected by ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:3-4, pages 246-255.
Read now
Shiran Salomon-Zimri, Avital Pushett, Niva Russek-Blum, Ruben P. A. Van Eijk, Nurit Birman, Beatrice Abramovich, Erez Eitan, Katya Elgrart, Danielle Beaulieu, David L. Ennist, James D. Berry, Sabrina Paganoni, Jeremy M. Shefner & Vivian E. Drory. (2023) Combination of ciprofloxacin/celecoxib as a novel therapeutic strategy for ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:3-4, pages 263-271.
Read now
Thomas Meyer, Susanne Spittel, Torsten Grehl, Ute Weyen, Robert Steinbach, Dagmar Kettemann, Susanne Petri, Patrick Weydt, René Günther, Petra Baum, Elena Schlapakow, Jan Christoph Koch, Matthias Boentert, Joachim Wolf, Julian Grosskreutz, Annekathrin Rödiger, Benjamin Ilse, Moritz Metelmann, Jenny Norden, Ruhan Yasemin Koc, Péter Körtvélyessy, Alessio Riitano, Bertram Walter, Barbara Hildebrandt, Friedrich Schaudinn, Christoph Münch & André Maier. (2023) Remote digital assessment of amyotrophic lateral sclerosis functional rating scale – a multicenter observational study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:3-4, pages 175-184.
Read now
Stefan Sennfält, Ulf Kläppe, Sebastian Thams, Kristin Samuelsson, Rayomand Press, Fang Fang & Caroline Ingre. (2023) Dying from ALS in Sweden: clinical status, setting, and symptoms. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:3-4, pages 237-245.
Read now
Carolyn A. Young, John Ealing, Christopher J. McDermott, Tim L. Williams, Ammar Al-Chalabi, Tahir Majeed, Kevin Talbot, Timothy Harrower, Christina Faull, Andrea Malaspina, Joe Annadale, Roger J. Mills & Alan Tennant. (2023) Measuring disability in amyotrophic lateral sclerosis/motor neuron disease: the WHODAS 2.0-36, WHODAS 2.0-32, and WHODAS 2.0-12. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:1-2, pages 63-70.
Read now
Roberto Teodoro Gurgel De Oliveira, Glauciane Costa Santana, Maria De Jesus Gonçalves, Guilherme Augusto De Freitas Fregonezi, Sancha Helena De Lima Vale, Lucia Leite-Lais & Mário Emílio Teixeira Dourado$suffix/text()$suffix/text(). (2023) A geographical study on amyotrophic lateral sclerosis in Rio Grande Do Norte, Brazil, from 2005 to 2018. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:1-2, pages 117-124.
Read now
R. J. Nona, J. M. Greer, R. D. Henderson & P. A. McCombe. (2023) HLA and amyotrophic lateral sclerosis: a systematic review and meta-analysis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:1-2, pages 24-32.
Read now
Stefan Sennfält, Ulf Kläppe, Sebastian Thams, Kristin Samuelsson, Rayomand Press, Fang Fang & Caroline Ingre. (2023) The path to diagnosis in ALS: delay, referrals, alternate diagnoses, and clinical progression. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:1-2, pages 45-53.
Read now
Hee Jo Han, Ha Young Shin, Young-Chul Choi, Seung Min Kim & Seung Woo Kim. (2022) Serum uric acid level predicts the progression of amyotrophic lateral sclerosis following treatment with edaravone. Redox Report 27:1, pages 79-84.
Read now
Claudia Vinciguerra, Antonella Toriello, Valerio Nardone, Daniele Romano, Salvatore Tartaglione, Filomena Abate, Annamaria Landolfi & Paolo Barone. (2022) Temporal muscle thickness and survival in patients with amyotrophic lateral sclerosis. Neurological Research 44:11, pages 1006-1010.
Read now
Xiaoxuan Liu, Ji He, Weiyi Yu & Dongsheng Fan. (2022) A de novo c.113 T > C: p.L38R mutation of SPTLC1: case report of a girl with sporadic juvenile amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:7-8, pages 634-637.
Read now
Giuseppe Borghero, Vincenzo Pierri, Rosario Vasta, Tommaso Ercoli, Giulia Primicerio, Francesca Pili, Angelo Fabio Gigante, Lorenzo Rocchi, Adriano Chiò & Giovanni Defazio. (2022) Incidence of amyotrophic lateral sclerosis in Sardinia, Italy: age–sex interaction and spatial–temporal variability. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:7-8, pages 585-591.
Read now
Anhar Hassan, Shivam O. Mittal, William T. Hu, Keith A. Josephs, Eric J. Sorenson & J. Eric Ahlskog. (2022) Does limited EMG denervation in early primary lateral sclerosis predict amyotrophic lateral sclerosis?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:7-8, pages 554-561.
Read now
Corey T. McMillan, Joanne Wuu, Katya Rascovsky, Stephanie Cosentino, Murray Grossman, Lauren Elman, Colin Quinn, Luis Rosario, Jessica H. Stark, Volkan Granit, Hannah Briemberg, Sneha Chenji, Annie Dionne, Angela Genge, Wendy Johnston, Lawrence Korngut, Christen Shoesmith, Lorne Zinman, Sanjay Kalra & Michael Benatar. (2022) Defining cognitive impairment in amyotrophic lateral sclerosis: an evaluation of empirical approaches. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:7-8, pages 517-526.
Read now
Cláudia Santos Silva, Miguel Oliveira Santos, Marta Gromicho, Ana Pronto-Laborinho, Isabel Conceição & Mamede de Carvalho. (2022) Motor neuron disease in three asymptomatic pVal50Met TTR gene carriers. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:7-8, pages 627-629.
Read now
Marie Beaudin, François Salachas, Pierre-François Pradat & Nicolas Dupré. (2022) Environmental risk factors for amyotrophic lateral sclerosis: a case–control study in Canada and France. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:7-8, pages 592-600.
Read now
Luca Diamanti, Elisa Bianchi, Klodjana Mucaj, Cristina Cereda, Silvio Garattini, Ettore Beghi & Elisabetta Pupillo. (2022) Drug treatments and interactions, disease progression and quality of life in ALS patients. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:5-6, pages 415-423.
Read now
Waqar Waheed, Fatima Khan, Shelly Naud, Edward Kasarskis, Dwight Matthews & Rup Tandan. (2022) Urine specific gravity to identify and predict hydration need in ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:5-6, pages 407-414.
Read now
Niki Panopoulou, Foteini Christidi, Panagiotis Kourtesis, Panagiotis Ferentinos, Panagiota Karampetsou, Georgios Tsirtsiridis, Thomas Theodosiou, Sofia Xirou, Vasiliki Zouvelou, Ioannis Evdokimidis, Michail Rentzos & Ioannis Zalonis. (2022) The association of theory of mind with language and visuospatial abilities in amyotrophic lateral sclerosis: a pilot study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:5-6, pages 462-469.
Read now
Christian Marques Couto, Elisa de Melo Queiroz, Renata Nogueira, Ana Paula Pires Duarte Küsel & Osvaldo J. M. Nascimento. (2022) A Brazilian multicentre study on the clinical and epidemiological profiles of 1116 patients with amyotrophic lateral sclerosis and its phenotypic variants. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:5-6, pages 353-362.
Read now
Giacomo Sferruzza, Luca Bosco, Yuri Matteo Falzone, Tommaso Russo, Teuta Domi, Angelo Quattrini, Massimo Filippi & Nilo Riva. (2022) Neurofilament light chain as a biological marker for amyotrophic lateral sclerosis: a meta-analysis study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:5-6, pages 446-457.
Read now
Elisa Bianchi, Elisabetta Pupillo, Antonio De Feudis, Gabriele Enia, Eugenio Vitelli & Ettore Beghi. (2022) Trends in survival of ALS from a population-based registry. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:5-6, pages 344-352.
Read now
Steve Vucic, Naomi Wray, Anjali Henders, Robert D. Henderson, Paul Talman, Susan Mathers, Matthew Bellgard, Samar Aoun, Carol Birks, Gethin Thomas, Catherine Hansen, Geoff Thomas, Anne Hogden, Merrilee Needham, David Schultz, Tina Soulis, Bec Sheean, Jane Milne, Dominic Rowe, Margie Zoing & Matthew C Kiernan. (2022) MiNDAUS partnership: a roadmap for the cure and management of motor Neurone disease. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:5-6, pages 321-328.
Read now
R.B. Mcgill, F.J. Steyn, S.T. Ngo, K.A. Thorpe, S. Heggie, R.D. Henderson, P.A. Mccombe & T.M. Woodruff. (2022) Monocyte CD14 and HLA-DR expression increases with disease duration and severity in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:5-6, pages 430-437.
Read now
Rosario Vasta, Luca Solero, Francesca Palumbo, Umberto Manera, Maria Claudia Torrieri, Maurizio Grassano, Antonio Canosa, Cristina Moglia, Andrea Calvo & Adriano Chiò. (2022) Can amyotrophic lateral sclerosis progression really pause? A cohort study using the medical research council scale. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:5-6, pages 383-389.
Read now
Zhengyi Cai, Qing Liu, Mingsheng Liu, Xunzhe Yang, Dongchao Shen, Xiaohan Sun, Di He, Kang Zhang, Liang Shang, Xue Zhang & Liying Cui. (2022) Survival analysis of clinical and genetic factors in an amyotrophic lateral sclerosis cohort from China. Neurological Research 44:7, pages 651-658.
Read now
Bernadette Wigand, Ina Schlichte, Stefanie Schreiber, Johanna Heitmann, Thomas Meyer, Reinhard Dengler, Susanne Petri, Aiden Haghikia, Stefan Vielhaber & Susanne Vogt. (2022) Characteristics of pain and the burden it causes in patients with amyotrophic lateral sclerosis – a longitudinal study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:3-4, pages 284-291.
Read now
Elisabetta Pupillo, Elisa Bianchi, Eugenio Vitelli & Ettore Beghi. (2022) ALS incidence and population aging in Northern Italy. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:3-4, pages 236-241.
Read now
Elisa Longinetti, Olafur Sveinsson, Rayomand Press, Weimin Ye, Caroline Ingre, Fredrik Piehl & Fang Fang. (2022) ALS patients with concurrent neuroinflammatory disorders; a nationwide clinical records study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:3-4, pages 209-219.
Read now
Rosario Vasta, Cristina Moglia, Umberto Manera, Antonio Canosa, Maurizio Grassano, Francesca Palumbo, Paolo Cugnasco, Fabiola De Marchi, Letizia Mazzini, Andrea Calvo & Adriano ChiÒ. (2022) What is amyotrophic lateral sclerosis prevalence?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:3-4, pages 203-208.
Read now
Alexander Kriss & Thomas Jenkins. (2022) Muscle MRI in motor neuron diseases: a systematic review. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:3-4, pages 161-175.
Read now
Mary Clare McKenna, Aizuri Murad, William Huynh, Jasmin Lope & Peter Bede. (2022) The changing landscape of neuroimaging in frontotemporal lobar degeneration: from group-level observations to single-subject data interpretation. Expert Review of Neurotherapeutics 22:3, pages 179-207.
Read now
WenChao Liu, XiaoGang Li, Yan Sun, XiaoTong Yu, Yan Wang, Na Liu & Min Deng. (2022) Genotype-phenotype correlations in a chinese population with familial amyotrophic lateral sclerosis. Neurological Research 44:3, pages 206-216.
Read now
Barbara Iazzolino, Debora Pain, Peotta Laura, Edoardo N. Aiello, Marcello Gallucci, Alice Radici, Francesca Palumbo, Antonio Canosa, Cristina Moglia, Andrea Calvo, Gabriele Mora & Adriano Chiò. (2022) Italian adaptation of the Beaumont Behavioral Inventory (BBI): psychometric properties and clinical usability. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:1-2, pages 81-86.
Read now
Ulf Kläppe, Sanharib Chamoun, Qing Shen, Anja Finn, Björn Evertsson, Henrik Zetterberg, Kaj Blennow, Rayomand Press, Kristin Samuelsson, Anna Månberg, Fang Fang & Caroline Ingre. (2022) Cardiac troponin T is elevated and increases longitudinally in ALS patients. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:1-2, pages 58-65.
Read now
Maria Claudia Torrieri, Umberto Manera, Gabriele Mora, Antonio Canosa, Rosario Vasta, Giuseppe Fuda, Paolina Salamone, Maurizio Grassano, Paolo Cugnasco, Nicola Launaro, Fabiola De Marchi, Alessio Mattei, Letizia Mazzini, Cristina Moglia, Andrea Calvo & Adriano Chiò. (2022) Tailoring patients’ enrollment in ALS clinical trials: the effect of disease duration and vital capacity cutoffs. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:1-2, pages 108-115.
Read now
Yuan Li, Yong Chen, Nan Zhang & Dongsheng Fan. (2022) Human endogenous retrovirus K (HERV-K) env in neuronal extracellular vesicles: a new biomarker of motor neuron disease. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:1-2, pages 100-107.
Read now
Francesco Pagnini, Deborah Phillips, Anne Haulman, Matthew Bankert, Zachary Simmons & Ellen Langer. (2022) An online non-meditative mindfulness intervention for people with ALS and their caregivers: a randomized controlled trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:1-2, pages 116-127.
Read now
Anne-Lene Kjældgaard, Katrine Pilely, Karsten Skovgaard Olsen, Anne Øberg Lauritsen, Stephen Wørlich Pedersen, Kirsten Svenstrup, Merete Karlsborg, Helle Thagesen, Morten Blaabjerg, Ásta Theódórsdóttir, Elisabeth Gundtoft Elmo, Anette Torvin Møller, Niels Anker Pedersen, Niels Kirkegaard, Kirsten Møller & Peter Garred. (2021) Complement Profiles in Patients with Amyotrophic Lateral Sclerosis: A Prospective Observational Cohort Study. Journal of Inflammation Research 14, pages 1043-1053.
Read now
Marta Gromicho, Magdalena Kuzma-Kozakiewicz, Katarzyna Szacka, Krzysztof Nieporecki, Peter M. Andersen, Julian Grosskreutz, Susanne Petri, Susana Pinto, Hilmi Uysal, Michael Swash & Mamede De Carvalho. (2021) Motor neuron disease beginning with frontotemporal dementia: clinical features and progression. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:7-8, pages 508-516.
Read now
Maia Farrugia Wismayer, Rebecca Borg, Andrew Farrugia Wismayer, Karl Bonavia, Malcolm Vella, Adrian Pace, Neville Vassallo & Ruben J. Cauchi. (2021) Occupation and amyotrophic lateral sclerosis risk: a case-control study in the isolated island population of Malta. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:7-8, pages 528-534.
Read now
Jaime Luna, Philippe Couratier, Sanae Lahmadi, Géraldine Lautrette, Andrea Fontana, Rosanna Tortelli, Giancarlo Logroscino, Pierre-Marie Preux, Massimilano Copetti & Marin Benoit. (2021) Comparison of the ability of the King’s and MiToS staging systems to predict disease progression and survival in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:7-8, pages 478-485.
Read now
Maximilian Vidovic, Elisa Aust, Andreas Hermann & René Günther. (2021) The palmomental reflex in amyotrophic lateral sclerosis – a clinical sign of executive or motor dysfunction?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:7-8, pages 588-591.
Read now
Manuel Pérez, Imanol Amayra, Oscar Martínez, Esther Lázaro, Juan Francisco López-Paz, Maitane García, Sarah Berrocoso, Mohammad Al-Rashaida, Alicia Aurora Rodríguez Bermejo, Paula María Luna & Luis Varona Franco. (2021) Signal-detection analysis of the WMS faces subtest: Results in amyotrophic lateral sclerosis patients. Applied Neuropsychology: Adult 28:5, pages 607-613.
Read now
Andrew Geronimo, Anne E. Martin & Zachary Simmons. (2021) Inertial sensing of step kinematics in ambulatory patients with ALS and related motor neuron diseases. Journal of Medical Engineering & Technology 45:6, pages 486-493.
Read now
Corrado Angelini & Gabriele Siciliano. (2021) An updated review on the role of prescribed exercise in the management of Amyotrophic lateral sclerosis. Expert Review of Neurotherapeutics 21:8, pages 871-879.
Read now
Stefania Bona, Giordana Donvito, Federica Cozza, Irene Malberti, Paolo Vaccari, Andrea Lizio, Lucia Greco, Elena Carraro, Valeria Ada Sansone & Christian Lunetta. (2021) The development of an augmented reality device for the autonomous management of the electric bed and the electric wheelchair for patients with amyotrophic lateral sclerosis: a pilot study. Disability and Rehabilitation: Assistive Technology 16:5, pages 513-519.
Read now
Nur Adilah Abdul Aziz, Tsun-Haw Toh, Ee-Chin Loh, David Paul Capelle, Khean-Jin Goh, Lydia Abdul Latif, Tze-Yang Chung & Nortina Shahrizaila. (2021) The utility of ALS staging systems in a multi-ethnic patient cohort. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:5-6, pages 341-349.
Read now
Ivonne Jericó, Itsaso Elizalde-Beiras, Inmaculada Pagola, Laura Torné, Arkaitz Galbete, Josu Delfrade-Osinaga & Esther Vicente. (2021) Clinical features and incidence trends of amyotrophic lateral sclerosis in Navarre, Spain, 2007–2018: a population-based study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:5-6, pages 401-409.
Read now
Panying Rong & Gary L. Pattee. (2021) A potential upper motor neuron measure of bulbar involvement in amyotrophic lateral sclerosis using jaw muscle coherence. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:5-6, pages 368-379.
Read now
Kinjal Thakor, Shelly Naud, Diantha Howard, Rup Tandan & Waqar Waheed. (2021) Effect of riluzole on weight in short-term and long-term survivors of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:5-6, pages 360-367.
Read now
Ahmad Al Khleifat, Rubika Balendra, Ton Fang & Ammar Al-Chalabi. (2021) Intuitive Staging Correlates With King’s Clinical Stage. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:5-6, pages 336-340.
Read now
Jashelle Caga, Margaret C. Zoing, David Foxe, Eleanor Ramsey, Mirelle D’Mello, Eneida Mioshi, Rebekah M. Ahmed, Matthew C. Kiernan & Olivier Piguet. (2021) Problem-focused coping underlying lower caregiver burden in ALS-FTD: implications for caregiver intervention. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:5-6, pages 434-441.
Read now
Toru Yamashita, Tetsuhiro Hatakeyama, Kota Sato, Yusuke Fukui, Nozomi Hishikawa, Mami Takemoto, Yasuyuki Ohta, Yoshihiro Nishiyama, Nobuyuki Kawai, Takashi Tamiya & Koji Abe. (2021) Hypoxic stress visualized in the cervical spinal cord of ALS patients. Neurological Research 43:6, pages 429-433.
Read now
Petra Steinacker, Emily Feneberg, Steffen Halbgebauer, Simon Witzel, Federico Verde, Patrick Oeckl, Philip Van Damme, Nayana Gaur, Elizabeth Gray, Julian Grosskreutz, Claude G. Jardel, Mykyta Kachanov, Jens Kuhle, Foudil Lamari, Aleksandra Maceski, Maria Del Mar Amador, Benjamin Mayer, Claudia Morelli, Susanne Petri, Koen Poesen, Joost Raaphorst, François Salachas, Vincenzo Silani, Martin R. Turner, Marcel M. Verbeek, Alexander E. Volk, Jochen H. Weishaupt, Patrick Weydt, Albert C. Ludolph & Markus Otto. (2021) Chitotriosidase as biomarker for early stage amyotrophic lateral sclerosis: a multicenter study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:3-4, pages 276-286.
Read now
Toru Sakurai, Shigeki Hirano, Midori Abe, Yuriko Uji, Keisuke Shimizu, Masahide Suzuki, Yoshikazu Nakano, Ai Ishikawa, Kazuho Kojima, Kazumoto Shibuya, Atsushi Murata & Satoshi Kuwabara. (2021) Dysfunction of the left angular gyrus may be associated with writing errors in ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:3-4, pages 267-275.
Read now
Michihito Masuda, Hirohisa Watanabe, Aya Ogura, Reiko Ohdake, Toshiyasu Kato, Kazuya Kawabata, Kazuhiro Hara, Ryoichi Nakamura, Naoki Atsuta, Bagarinao Epifanio, Masahisa Katsuno & Gen Sobue. (2021) Clinicoradiological features in amyotrophic lateral sclerosis patients with olfactory dysfunction. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:3-4, pages 260-266.
Read now
Monica Consonni, Eleonora Dalla Bella, Enrica Bersano, Alessandra Telesca & Giuseppe Lauria. (2021) Cognitive reserve is associated with altered clinical expression in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:3-4, pages 237-247.
Read now
Jeremy M. Shefner, Jinsy A. Andrews, Angela Genge, Carlayne Jackson, Noah Lechtzin, Timothy M. Miller, Bettina M. Cockroft, Lisa Meng, Jenny Wei, Andrew A. Wolff, Fady I. Malik, Cynthia Bodkin, Benjamin R. Brooks, James Caress, Annie Dionne, Dominic Fee, Stephen A. Goutman, Namita A. Goyal, Orla Hardiman, Ghazala Hayat, Terry Heiman-Patterson, Daragh Heitzman, Robert D. Henderson, Wendy Johnston, Chafic Karam, Matthew C. Kiernan, Stephen J. Kolb, Lawrence Korngut, Shafeeq Ladha, Genevieve Matte, Jesus S. Mora, Merrilee Needham, Bjorn Oskarsson, Gary L. Pattee, Erik P. Pioro, Michael Pulley, Dianna Quan, Kourosh Rezania, Kerri L. Schellenberg, David Schultz, Christen Shoesmith, Zachary Simmons, Jeffrey Statland, Shumaila Sultan, Andrea Swenson, Leonard H. Van Den Berg, Tuan Vu, Steve Vucic, Michael Weiss, Ashley Whyte-Rayson, James Wymer, Lorne Zinman & Stacy A. Rudnicki. (2021) A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of Reldesemtiv In Patients With ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:3-4, pages 287-299.
Read now
Hebatallah R. Rashed, Mohamed A. Tork, Radwa Soliman, Rehab Serag & Nagia Fahmy. (2021) Arabic adaptation and validation of the revised amyotrophic lateral sclerosis functional rating scale (ALSFRS-R): Egyptian study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:3-4, pages 220-222.
Read now
Yueh-Lin Tsai & James L. Manley. (2021) Multiple ways to a dead end: diverse mechanisms by which ALS mutant genes induce cell death. Cell Cycle 20:7, pages 631-646.
Read now
Masayuki Sato, Takumi Nakamura, Kazuaki Nagashima, Yukio Fujita & Yoshio Ikeda. (2021) Prolonged distal latency of the median motor nerve is associated with poor prognosis in amyotrophic lateral sclerosis. Neurological Research 43:3, pages 191-198.
Read now
Arianna Palmieri, Johann R. Kleinbub, Francesco Pagnini, Gianni Sorarù & Sabrina Cipolletta. (2021) Empathy-based supportive treatment in amyotrophic lateral sclerosis: A pragmatic study. American Journal of Clinical Hypnosis 63:3, pages 202-216.
Read now
Nur Adilah Abdul Aziz, Tsun-Haw Toh, Khean-Jin Goh, Ee-Chin Loh, David Paul Capelle, Lydia Abdul Latif, Alex Hwong-Ruey Leow, Carolyn Chue-Wai Yim, Mohd Fitry Zainal Abidin, Shairil Rahayu Ruslan & Nortina Shahrizaila. (2021) Natural history and clinical features of ALS in Malaysia. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:1-2, pages 108-116.
Read now
Susana Pinto, Michael Swash & Mamede De Carvalho. (2021) Mouth occlusion pressure at 100ms (P0.1) as a respiratory biomarker in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:1-2, pages 53-60.
Read now
Hilmi Uysal, Parvin Taghiyeva, Mehtap Türkay, Fırat Köse & Mehmet Aktekin. (2021) Amyotrophic lateral sclerosis in Antalya, Turkey. A prospective study, 2016–2018. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:1-2, pages 101-107.
Read now
Francesca Trojsi, Federica Di Nardo, Mattia Siciliano, Giuseppina Caiazzo, Carla Passaniti, Giulia D’Alvano, Dario Ricciardi, Antonio Russo, Alvino Bisecco, Luigi Lavorgna, Simona Bonavita, Mario Cirillo, Fabrizio Esposito & Gioacchino Tedeschi. (2021) Resting state functional MRI brain signatures of fast disease progression in amyotrophic lateral sclerosis: a retrospective study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:1-2, pages 117-126.
Read now
Magdalena Kuźma-Kozakiewicz, Peter M. Andersen, Elahe Elahi, Afagh Alavi, Peter C. Sapp, Mitsuya Morita, Cezary Żekanowski & Mariusz Berdyński. (2021) Putative founder effect in the Polish, Iranian and United States populations for the L144S SOD1 mutation associated with slowly uniform phenotype of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:1-2, pages 80-85.
Read now
Yasuhiro Watanabe, Mieko Ogino, Hiroo Ichikawa, Ritsuko Hanajima & Kenji Nakashima. (2021) The Edinburgh Cognitive and Behavioural ALS Screen (ECAS) for Japanese ALS and FTD patients. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:1-2, pages 66-72.
Read now
Zhang-Yu Zou, Chun-Hui Che, Shu-Yan Feng, Xiu-Ying Fang, Hua-Pin Huang & Chang-Yun Liu. (2021) Novel FUS mutation Y526F causing rapidly progressive familial amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:1-2, pages 73-79.
Read now
Jianing Lin, Weineng Chen, Pian Huang, Youna Xie, Minying Zheng & Xiaoli Yao. (2021) The distinct manifestation of young-onset amyotrophic lateral sclerosis in China. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:1-2, pages 30-37.
Read now
Tina Taule, Margaret Søvik, Regina Küfner Lein, Eike Wehling, Jörg Aßmus & Tiina Rekand. (2020) Psychometric Properties of Cognitive Assessment in Amyotrophic Lateral Sclerosis: A Systematic Review. Patient Related Outcome Measures 11, pages 181-194.
Read now
Tino Prell, Otto W. Witte, Anne Gunkel & Julian Grosskreutz. (2020) Cognitive deficits have only limited influence on health-related quality of life in amyotrophic lateral sclerosis. Aging & Mental Health 24:12, pages 1963-1967.
Read now
Mamede de Carvalho, Matthew C. Kiernan, Seth L Pullman, Kourosh Rezania, MR Turner & Zachary Simmons. (2020) Neurophysiological features of primary lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:sup1, pages 11-17.
Read now
Deborah Mudali, Jaison Jeevanandam & Michael K. Danquah. (2020) Probing the characteristics and biofunctional effects of disease-affected cells and drug response via machine learning applications. Critical Reviews in Biotechnology 40:7, pages 951-977.
Read now
Andrew Geronimo & Zachary Simmons. (2020) TeleBCI: remote user training, monitoring, and communication with an evoked-potential brain-computer interface. Brain-Computer Interfaces 7:3-4, pages 57-69.
Read now
Jennifer A. Saxon, Jennifer C. Thompson, Jennifer M. Harris, John Ealing, Hisham Hamdalla, Amina Chaouch, Carolyn Young, Daniel Blackburn, Tahir Majeed, Claire Gall, Anna M.T. Richardson, Tobias Langheinrich, Matthew Jones & Julie S. Snowden. (2020) The Edinburgh Cognitive and Behavioral ALS Screen (ECAS) in frontotemporal dementia. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:7-8, pages 606-613.
Read now
Michael A. Van Es, Ruben P.A. Van Eijk, Tommy M. Bunte & Leonard H. Van Den Berg. (2020) A placebo-controlled trial to investigate the safety and efficacy of Penicillin G/Hydrocortisone in patients with ALS (PHALS trial). Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:7-8, pages 584-592.
Read now
Rosa Capozzo, Stefano Zoccolella, Marco Musio, Roberta Barone, Miriam Accogli & Giancarlo Logroscino. (2020) Telemedicine is a useful tool to deliver care to patients with Amyotrophic Lateral Sclerosis during COVID-19 pandemic: results from Southern Italy. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:7-8, pages 542-548.
Read now
Michael A. van Es, H. Stephan Goedee, Henk-Jan Westeneng, Tanja C.W. Nijboer & Leonard H. van den Berg. (2020) Is it accurate to classify ALS as a neuromuscular disorder?. Expert Review of Neurotherapeutics 20:9, pages 895-906.
Read now
Tom Burke, Marta Pinto-Grau, Emmet Costello, Colm Peelo, Katie Lonergan, Mark Heverin, Orla Hardiman & Niall Pender. (2020) The reading the mind in the eyes test short form (A & B): validation and outcomes in an amyotrophic lateral sclerosis cohort. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:5-6, pages 380-388.
Read now
Enrica Bersano, Maria Francesca Sarnelli, Valentina Solara, Barbara Iazzolino, Laura Peotta, Fabiola De Marchi, Alessio Facchin, Cristina Moglia, Antonio Canosa, Andrea Calvo, Adriano Chiò & Letizia Mazzini. (2020) Decline of cognitive and behavioral functions in amyotrophic lateral sclerosis: a longitudinal study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:5-6, pages 373-379.
Read now
Hebatallah R. Rashed & Mohamed A. Tork. (2020) Diagnostic delay among ALS patients: Egyptian study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:5-6, pages 416-419.
Read now
Lev Brylev, Anastasia Ataulina, Vera Fominykh, Vadim Parshikov, Anna Vorobyeva, Elena Istomina, Rafiz Shikhirimov, Alexandr Salikov, Mariya Zakharova, Alla Guekht & Ettore Beghi. (2020) The epidemiology of amyotrophic lateral sclerosis in Moscow (Russia). Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:5-6, pages 410-415.
Read now
Carolyn A. Young, Roger Mills, Ammar Al-Chalabi, Georgina Burke, Siddharthan Chandran, David J Dick, John Ealing, C. Oliver Hanemann, Timothy Harrower, Christopher J. Mcdermott, Tahir Majeed, Ashwin Pinto, Kevin Talbot, Jannette Walsh, Timothy L. Williams & Alan Tennant. (2020) Measuring quality of life in ALS/MND: validation of the WHOQOL-BREF. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:5-6, pages 364-372.
Read now
Elisa Baldin, Pierre-Marie Preux, Philippe Couratier, Maura Pugliatti & Benoit Marin. (2020) Validity of death certificates in the identification of cases of amyotrophic lateral sclerosis (ALS) in the Limousin region, France. A population-based study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:3-4, pages 228-234.
Read now
Hiroshi Mitsumoto, Diana C. Garofalo, Regina M. Santella, Eric J. Sorenson, Björn Oskarsson, J americo M. Fernandes$suffix/text()$suffix/text(), Howard Andrews, Jonathan Hupf, Madison Gilmore, Daragh Heitzman, Richard S. Bedlack, Jonathan S. Katz, Richard J. Barohn, Edward J. Kasarskis, Catherine lomen-Hoerth, Tahseen Mozaffar, Sharon P. Nations, Andrea J. Swenson & Pam Factor-Litvak. (2020) Plasma creatinine and oxidative stress biomarkers in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:3-4, pages 263-272.
Read now
Daniela Pimenta Silva, Mariana Soeiro E Sá, Fernando Silveira, Susana Pinto, Marta Gromicho, Ana Berta Sousa, Miguel Leão & Mamede De Carvalho. (2020) VRK1 variants in two Portuguese unrelated patients with childhood-onset motor neuron disease. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:3-4, pages 291-295.
Read now
Linjing Zhang, Lu Chen & Dongsheng Fan. (2020) The protective role of pre-morbid type 2 diabetes in patients with amyotrophic lateral sclerosis: a center-based survey in China. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:3-4, pages 209-215.
Read now
William Huynh, Rebekah Ahmed, Colin J. Mahoney, Chilan Nguyen, Sicong Tu, Jashelle Caga, Patricia Loh, Cindy S-Y Lin & Matthew C. Kiernan. (2020) The impact of cognitive and behavioral impairment in amyotrophic lateral sclerosis. Expert Review of Neurotherapeutics 20:3, pages 281-293.
Read now
Jan Kassubek & Hans-Peter Müller. (2020) Advanced neuroimaging approaches in amyotrophic lateral sclerosis: refining the clinical diagnosis. Expert Review of Neurotherapeutics 20:3, pages 237-249.
Read now
So Young Pyun, Yerim Kim, Seong-Il Oh & Jong Seok Bae. (2020) Differences in nerve excitability properties between isolated bulbar palsy and bulbar-dominant amyotrophic lateral sclerosis. Neurological Research 42:2, pages 133-140.
Read now
C. Morelli, C. Tiloca, C. Colombrita, A. Zambon, D. Soranna, A. Lafronza, F. Solca, L. Carelli, B. Poletti, A. Doretti, F. Verde, L. Maderna, N. Ticozzi, A. Ratti & V. Silani. (2020) CSF angiogenin levels in amyotrophic lateral Sclerosis-Frontotemporal dementia spectrum. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:1-2, pages 63-69.
Read now
Imen Kacem, Ikram Sghaier, Sabrine Bougatef, Amina Nasri, Amina Gargouri, Senda Ajroud-Driss & Riadh Gouider. (2020) Epidemiological and clinical features of amyotrophic lateral sclerosis in a Tunisian cohort. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:1-2, pages 131-139.
Read now
Carolina Barnett, Jordan R. Green, Reeman Marzouqah, Kaila L. Stipancic, James D. Berry, Lawrence Korngut, Angela Genge, Christen Shoesmith, Hannah Briemberg, Agessandro Abrahao, Sanjay Kalra, Lorne Zinman & Yana Yunusova. (2020) Reliability and validity of speech & pause measures during passage reading in ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:1-2, pages 42-50.
Read now
Reshma Punjani, Laurie Wagner, Kevin Horton & Wendy Kaye. (2020) Atlanta metropolitan area amyotrophic lateral sclerosis (ALS) surveillance: incidence and prevalence 2009–2011 and survival characteristics through 2015. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:1-2, pages 123-130.
Read now
Suma Babu, Eric A. Macklin, Katherine E. Jackson, Elizabeth Simpson, Katy Mahoney, Hong Yu, Jason Walker, Zachary Simmons, William S. David, Paul E. Barkhaus, Laura Simionescu, Mazen M. Dimachkie, Alan Pestronk, Johnny S. Salameh, Michael D. Weiss, Benjamin Rix Brooks, David Schoenfeld, Jeremy Shefner, Swati Aggarwal, Merit E. Cudkowicz & Nazem Atassi. (2020) Selection design phase II trial of high dosages of tamoxifen and creatine in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:1-2, pages 15-23.
Read now
Nathalie Braun, Eric A. Macklin, Ervin Sinani, Alexander Sherman & Markus Weber. (2020) The revised El Escorial criteria “clinically probable laboratory supported ALS”—once a promising now a superfluous category?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:1-2, pages 24-28.
Read now
Lu Chen, Lu Tang & Dongsheng Fan. (2020) Twelve-month duration as an appropriate criterion for flail arm syndrome. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:1-2, pages 29-33.
Read now
Panagiotis Kourtesis, Foteini Christidi, Eleni Margioti, Christina Demenega, Michail Rentzos, Ioannis Evdokimidis & Sharon Abrahams. (2020) The Edinburgh cognitive and behavioral amyotrophic lateral sclerosis screen (ECAS): sensitivity in differentiating between ALS and Alzheimer’s disease in a Greek population. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:1-2, pages 78-85.
Read now
Jesus S. Mora, Angela Genge, Adriano Chio, Conrado J. Estol, Delia Chaverri, Maria Hernández, Saúl Marín, Javier Mascias, Gabriel E. Rodriguez, Monica Povedano, Andrés Paipa, Raul Dominguez, Josep Gamez, Maria Salvado, Christian Lunetta, Carlos Ballario, Nilo Riva, Jessica Mandrioli, Alain Moussy, Jean-Pierre Kinet, Christian Auclair, Patrice Dubreuil, Vincent Arnold, Colin D. Mansfield & Olivier Hermine. (2020) Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:1-2, pages 5-14.
Read now
Boeun Kim, Youri Jin, Seung Hyun Kim & Yongsoon Park. (2020) Association between macronutrient intake and amyotrophic lateral sclerosis prognosis. Nutritional Neuroscience 23:1, pages 8-15.
Read now
Stephanie L Barnes & Neil G Simon. (2019) Clinical and research applications of neuromuscular ultrasound in amyotrophic lateral sclerosis. Degenerative Neurological and Neuromuscular Disease 9, pages 89-102.
Read now
Peter D. Fransquet & Joanne Ryan. (2019) The current status of blood epigenetic biomarkers for dementia. Critical Reviews in Clinical Laboratory Sciences 56:7, pages 435-457.
Read now
Michele Barone, Maria Teresa Viggiani, Alessandro Introna, Eustachio D’errico, Antonio Scarafino, Andrea Iannone, Alfredo Di Leo & Isabella Laura Simone. (2019) Nutritional prognostic factors for survival in amyotrophic lateral sclerosis patients undergone percutaneous endoscopic gastrostomy placement. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:7-8, pages 490-496.
Read now
Shyuan T. Ngo, Ruben P.A. van Eijk, V. Chachay, Leonard H. van den Berg, Pamela A. McCombe, Robert D. Henderson & Frederik J. Steyn. (2019) Loss of appetite is associated with a loss of weight and fat mass in patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:7-8, pages 497-505.
Read now
Kirsty R. Weeks, Rebecca L. Gould, Christopher Mcdermott, Jessica Lynch, Laura H. Goldstein, Christopher D. Graham, Lance McCracken, Marc Serfaty, Robert Howard, Ammar Al-Chalabi, David White, Mike Bradburn, Tracey Young, Cindy Cooper, Dame Pamela J. Shaw & Vanessa Lawrence. (2019) Needs and preferences for psychological interventions of people with motor neuron disease. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:7-8, pages 521-531.
Read now
Jeremy M. Shefner, Merit E. Cudkowicz, Orla Hardiman, Bettina M. Cockroft, Jacqueline H. Lee, Fady I. Malik, Lisa Meng, Stacy A. Rudnicki, Andrew A. Wolff & Jinsy A. Andrews. (2019) A phase III trial of tirasemtiv as a potential treatment for amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:7-8, pages 584-594.
Read now
Sanjana Shellikeri, Matthew Myers, Sandra E. Black, Agessandro Abrahao, Lorne Zinman & Yana Yunusova. (2019) Speech network regional involvement in bulbar ALS: a multimodal structural MRI study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:5-6, pages 385-395.
Read now
Hiroshi Mitsumoto, Codruta Chiuzan, Madison Gilmore, Yuan Zhang, Camila Ibagon, Brittany McHale, Jonathan Hupf & BjÖrn Oskarsson. (2019) A novel muscle cramp scale (MCS) in amyotrophic lateral sclerosis (ALS). Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:5-6, pages 328-335.
Read now
Scott L.M. Johns, Abdullah Ishaque, Muhammad Khan, Yee-Hong Yang, Alan H. Wilman & Sanjay Kalra. (2019) Quantifying changes on susceptibility weighted images in amyotrophic lateral sclerosis using MRI texture analysis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:5-6, pages 396-403.
Read now
Michael Benatar, Martin R. Turner & Joanne Wuu. (2019) Defining pre-symptomatic amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:5-6, pages 303-309.
Read now
Andrew Geronimo & Zachary Simmons. (2019) Evaluation of remote pulmonary function testing in motor neuron disease. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:5-6, pages 348-355.
Read now
Pingping Ning, Baiyuan Yang, Shuangjiang Li, Xin Mu, Qiuyan Shen, Fayun Hu, Yao Tang, Xinglong Yang & Yanming Xu. (2019) Systematic review of the prognostic role of body mass index in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:5-6, pages 356-367.
Read now
Danielle Leighton, Judith Newton, Shuna Colville, Andrew Bethell, Gillian Craig, Laura Cunningham, Moira Flett, Dianne Fraser, Janice Hatrick, Helen Lennox, Laura Marshall, Dympna McAleer, Alison McEleney, Kitty Millar, Ann Silver, Laura Stephenson, Susan Stewart, Dorothy Storey, Gill Stott, Carol Thornton, Carolyn Webber, Harry Gordon, Giulia Melchiorre, Laura Sherlock, Emily Beswick, David Buchanan, Sharon Abrahams, Anthony Bateman, Jenny Preston, Callum Duncan, Richard Davenport, George Gorrie, Ian Morrison, Robert Swingler, Siddharthan Chandran & Suvankar Pal. (2019) Clinical audit research and evaluation of motor neuron disease (CARE-MND): a national electronic platform for prospective, longitudinal monitoring of MND in Scotland. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:3-4, pages 242-250.
Read now
Hui-Xia Lin, Qing-Qing Tao, Qiao Wei, Cong-Xin Chen, Yu-Chao Chen, Hong-Fu Li, Aaron D. Gitler & Zhi-Ying Wu. (2019) Identification and functional analysis of novel mutations in the SOD1 gene in Chinese patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:3-4, pages 222-228.
Read now
George H. Gorrie, Siddharthan Chandran, Shuna Colville, Judith Newton, Danielle Leighton, Menai Mcdonald, Suvankar Pal, Raeburn Forbes, Mario Hair & Robert Swingler. (2019) Improved survival and 30-day mortality after gastrostomy in Scottish motor neurone disease patients: evidence from a national retrospective cohort study using STROBE criteria. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:3-4, pages 165-171.
Read now
Qionghua Sun, Fei Yang, Hongfen Wang, Fang Cui, Yanran Li, Siyuan Li, Yuting Ren, Wenjie Lan, Mao Li, Wenjia Zhu, Xiaosun Sun, Zhengqing He, Xue Zhao, Li Yang & Xusheng Huang. (2019) Elevated serum ferritin level as a predictor of reduced survival in patients with sporadic amyotrophic lateral sclerosis in China: a retrospective study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:3-4, pages 186-191.
Read now
Eoin Finegan, Rangariroyashe H. Chipika, Stacey Li Hi Shing, Orla Hardiman & Peter Bede. (2019) Primary lateral sclerosis: a distinct entity or part of the ALS spectrum?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:3-4, pages 133-145.
Read now
Jessica de Wit, Leonhard A. Bakker, Annerieke C. van Groenestijn, Joost F. Baardman, Leonard H. van den Berg, Johanna M.A. Visser-Meily & Carin D. SchrÖder. (2019) Psychological distress and coping styles of caregivers of patients with amyotrophic lateral sclerosis: a longitudinal study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:3-4, pages 235-241.
Read now
EglĖ SukockienĖ, Gilles Allali, Jean-Paul Janssens & Ruxandra Iancu Ferfoglia. (2019) Does executive functioning contribute to locomotion in amyotrophic lateral sclerosis patients?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:1-2, pages 123-125.
Read now
Shan Ye, Angela Rosenbohm, Sarah Böhm, Ingo Uttner, Ying Ji, Albert C. Ludolph, Dorothée Lulé & Dongsheng Fan. (2019) Cognitive and behavioral impairments in German and Chinese ALS populations – a post-hoc comparison of national study data. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:1-2, pages 28-36.
Read now
JosÉ E. de la Rubia, Eraci Drehmer, JosÉ L. Platero, MarÍa Benlloch, Jordi Caplliure-Llopis, Carlos Villaron-Casales, Nieves de Bernardo, Jorge AlarcÓn, Cristian Fuente, Sandra Carrera, David Sancho, Pilar GarcÍa-Pardo, Raquel Pascual, Marta JuÁrez, María Cuerda-Ballester, Alfonso Forner, Sandra Sancho-Castillo, Carlos Barrios, Elena Obrador, Patricia Marchio, Rosario Salvador, Holly E. Holmes, Ryan W. Dellinger, Leonard Guarente & José M. Estrela. (2019) Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled human pilot study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:1-2, pages 115-122.
Read now
Nilda Turgut, Gamze Varol SaraÇoglu, Selahattin Kat, Kemal Balci, BabÜrhan GÜldiken, Ozlem Birgili & Levent Kabayel. (2019) An epidemiologic investigation of amyotrophic lateral sclerosis in Thrace, Turkey, 2006–2010*. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:1-2, pages 100-106.
Read now
Leonhard A. Bakker, Carin D. Schröder, Lauriane A. Spreij, Marianne Verhaegen, Joke De Vocht, Philip Van Damme, Jan H. Veldink, Johanna M.A. Visser-Meily, Leonard H. van den Berg, Tanja C.W. Nijboer & Michael A. van Es. (2019) Derivation of norms for the Dutch version of the Edinburgh cognitive and behavioral ALS screen. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:1-2, pages 19-27.
Read now
Francesca Palese, Arianna Sartori, Lorenzo Verriello, Silvia Ros, Paolo Passadore, Paolo Manganotti, Fabio Barbone & Federica Edith Pisa. (2019) Epidemiology of amyotrophic lateral sclerosis in Friuli-Venezia Giulia, North-Eastern Italy, 2002–2014: a retrospective population-based study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:1-2, pages 90-99.
Read now
Amresh Prakash, Vijay Kumar, Naveen Kumar Meena, Md. Imtaiyaz Hassan & Andrew M. Lynn. (2019) Comparative analysis of thermal unfolding simulations of RNA recognition motifs (RRMs) of TAR DNA-binding protein 43 (TDP-43). Journal of Biomolecular Structure and Dynamics 37:1, pages 178-194.
Read now
Alessandro Introna, Eustachio D’Errico, Boris Modugno, Antonio Scarafino, Angela Fraddosio, Eugenio Distaso, Irene Tempesta, Antonella Mastronardi & Isabella Laura Simone. (2018) Adherence to riluzole in patients with amyotrophic lateral sclerosis: an observational study. Neuropsychiatric Disease and Treatment 14, pages 193-203.
Read now
. (2018) Theme 10 Disease stratification and phenotyping. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:sup1, pages 282-300.
Read now
. (2018) Theme 6 Tissue biomarkers. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:sup1, pages 198-216.
Read now
Arens Taga & Nicholas J. Maragakis. (2018) Current and emerging ALS biomarkers: utility and potential in clinical trials. Expert Review of Neurotherapeutics 18:11, pages 871-886.
Read now
Espen Benjaminsen, Karl B. Alstadhaug, Marie Gulsvik, Farid K. Baloch & Francis Odeh. (2018) Amyotrophic lateral sclerosis in Nordland county, Norway, 2000–2015: prevalence, incidence, and clinical features. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:7-8, pages 522-527.
Read now
Miguel Oliveira Santos, Marta Gromicho, Susana Pinto & Mamede de Carvalho. (2018) Very late-onset amyotrophic lateral sclerosis in a Portuguese cohort. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:7-8, pages 619-622.
Read now
Michihito Masuda, Hirohisa Watanabe, Yasuhiro Tanaka, Reiko Ohdake, Aya Ogura, Takamasa Yokoi, Kazunori Imai, Kazuya Kawabata, Yuichi Riku, Kazuhiro Hara, Ryoichi Nakamura, Naoki Atsuta, Masahisa Katsuno & Gen Sobue. (2018) Age-related impairment in Addenbrooke’s cognitive examination revised scores in patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:7-8, pages 578-584.
Read now
Jeremy M. Shefner, Seward B. Rutkove, James B. Caress, Michael Benatar, William S. David, Michael S. Cartwright, Eric A. Macklin & Jose L. Bohorquez. (2018) Reducing sample size requirements for future ALS clinical trials with a dedicated electrical impedance myography system. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:7-8, pages 555-561.
Read now
Jashelle Caga, Sharpley Hsieh, Elizabeth Highton-Williamson, Margaret C. Zoing, Eleanor Ramsey, Emma Devenney, Rebekah M. Ahmed, Anne Hogden & Matthew C. Kiernan. (2018) The burden of apathy for caregivers of patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:7-8, pages 599-605.
Read now
Elisa Longinetti, Amanda Regodón Wallin, Kristin Samuelsson, Rayomand Press, Anne Zachau, Lars-Olof Ronnevi, Marie Kierkegaard, Peter M Andersen, Jan Hillert, Fang Fang & Caroline Ingre. (2018) The Swedish motor neuron disease quality registry. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:7-8, pages 528-537.
Read now
N. Arwas, A. Leshno & M. Gotkine. (2018) The palmomental reflex predicts earlier corticobulbar involvement in ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:7-8, pages 513-515.
Read now
Jong Moon Kim, Jung Hyun Park, Hyung Seop Kim, Jang Woo Lee, Hyun Sun Lim, Won Ah Choi & Seong-Woong Kang. (2018) Epidemiology and diagnostic process of amyotrophic lateral sclerosis as distinct from myelopathy: 5-year cohort study of whole-population in South Korea. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:7-8, pages 547-554.
Read now
Ludovic D’hulst, Donatienne Van Weehaeghe, Adriano Chiò, Andrea Calvo, Cristina Moglia, Antonio Canosa, Angelina Cistaro, Stefanie Ma Willekens, Joke De Vocht, Philip Van Damme, Marco Pagani & Koen Van Laere. (2018) Multicenter validation of [18F]-FDG PET and support-vector machine discriminant analysis in automatically classifying patients with amyotrophic lateral sclerosis versus controls. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:7-8, pages 570-577.
Read now
Daniel Harrison, Paul Mehta, Michael A. van Es, Elijah Stommel, Vivian E. Drory, Beatrice Nefussy, Leonard H. van den Berg, Jesse Crayle & Richard Bedlack. (2018) “ALS reversals”: demographics, disease characteristics, treatments, and co-morbidities. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:7-8, pages 495-499.
Read now
Yanran Li, Bo Sun, Siyu Chen, Yuting Ren, Fang Cui, Fei Yang, Zhaohui Chen, Li Ling & Xusheng Huang. (2018) A novel D90_K91insN mutation in exon 4 of the SOD1 gene caused familial amyotrophic lateral sclerosis in a Chinese pedigree. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:7-8, pages 516-521.
Read now
Barbara Poletti, Federica Solca, Laura Carelli, Andrea Faini, Fabiana Madotto, Annalisa Lafronza, Alessia Monti, Stefano Zago, Andrea Ciammola, Antonia Ratti, Nicola Ticozzi, Sharon Abrahams & Vincenzo Silani. (2018) Cognitive-behavioral longitudinal assessment in ALS: the Italian Edinburgh Cognitive and Behavioral ALS screen (ECAS). Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:5-6, pages 387-395.
Read now
Beata Peplonska, Mariusz Berdynski, Monika Mandecka, Anna Barczak, Magdalena Kuzma-Kozakiewicz, Maria Barcikowska & Cezary Zekanowski. (2018) TREM2 variants in neurodegenerative disorders in the Polish population. Homozygosity and compound heterozygosity in FTD patients. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:5-6, pages 407-412.
Read now
Philippe Corcia, Patrick Vourc’h, Helene Blasco, Philippe Couratier, Audrey Dangoumau, Remi Bellance, Claude Desnuelle, Fausto Viader, Vivien Pautot, Stephanie Millecamps, Salah Bakkouche, FranÇois Salachas, Christian R. Andres, Vincent Meininger & William Camu. (2018) Phenotypic and genotypic studies of ALS cases in ALS-SMA families. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:5-6, pages 432-437.
Read now
Zhouwei Xu, Aven Lee, Amanda Nouwens, Robert David Henderson & Pamela Ann McCombe. (2018) Mass spectrometry analysis of plasma from amyotrophic lateral sclerosis and control subjects. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:5-6, pages 362-376.
Read now
Hang Zhang, Wanshi Cai, Siyu Chen, Jialong Liang, Zhanjun Wang, Yuting Ren, Wenxiu Liu, Xiaolan Zhang, Zhongsheng Sun & Xusheng Huang. (2018) Screening for possible oligogenic pathogenesis in Chinese sporadic ALS patients. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:5-6, pages 419-425.
Read now
Philippe Codron, Julien Cassereau, Patrick Vourc’h, Charlotte Veyrat-Durebex, Hélène Blasco, Selma Kane, Vincent Procaccio, Franck Letournel, Christophe Verny, Guy Lenaers, Pascal Reynier & Arnaud Chevrollier. (2018) Primary fibroblasts derived from sporadic amyotrophic lateral sclerosis patients do not show ALS cytological lesions. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:5-6, pages 446-456.
Read now
Yongping Chen, Qingqing Zhou, Xiaojing Gu, Qianqian Wei, Bei Cao, Hui Liu, Yanbing Hou & Huifang Shang. (2018) An association study between SCFD1 rs10139154 variant and amyotrophic lateral sclerosis in a Chinese cohort. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:5-6, pages 413-418.
Read now
Jinsy A. Andrews, Merit E. Cudkowicz, Orla Hardiman, Lisa Meng, Amy Bian, Jacqueline Lee, Andrew A. Wolff, Fady I. Malik & Jeremy M. Shefner. (2018) VITALITY-ALS, a phase III trial of tirasemtiv, a selective fast skeletal muscle troponin activator, as a potential treatment for patients with amyotrophic lateral sclerosis: study design and baseline characteristics. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:3-4, pages 259-266.
Read now
Connor N. Scagnelli, Diantha B. Howard, Mark B. Bromberg, Edward J. Kasarskis, Dwight E. Matthews, Hiroshi M. Mitsumoto, Zachary Simmons & Rup Tandan. (2018) Hydration measured by doubly labeled water in ALS and its effects on survival. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:3-4, pages 220-231.
Read now
Peter Bede & Orla Hardiman. (2018) Longitudinal structural changes in ALS: a three time-point imaging study of white and gray matter degeneration. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:3-4, pages 232-241.
Read now
Tanja Makkonen, Hanna Ruottinen, Anna-Maija Korpijaakko-Huuhka & Johanna Palmio. (2018) Variation in communication strategies in amyotrophic lateral sclerosis during a two-year follow-up. Speech, Language and Hearing 21:2, pages 123-130.
Read now
Jesús S. Mora, Teresa Salas, María Camino Fernández, Víctor Rodríguez-Castillo, Saúl Marín, Delia Chaverri & Francisco Rodríguez-Santos. (2018) Spanish adaptation of the edinburgh cognitive and behavioral amyotrophic lateral sclerosis screen (ECAS). Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:1-2, pages 74-79.
Read now
Foteini Christidi, Efstratios Karavasilis, Panagiotis Ferentinos, Sophia Xirou, Georgios Velonakis, Michalis Rentzos, Vasiliki Zouvelou, Ioannis Zalonis, Efstathios Efstathopoulos, Nikolaos Kelekis & Ioannis Evdokimidis. (2018) Investigating the neuroanatomical substrate of pathological laughing and crying in amyotrophic lateral sclerosis with multimodal neuroimaging techniques. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:1-2, pages 12-20.
Read now
Renée Walhout, Esther Verstraete, Martijn P. van den Heuvel, Jan H. Veldink & Leonard H. van den Berg. (2018) Patterns of symptom development in patients with motor neuron disease. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:1-2, pages 21-28.
Read now
Juyeon Oh & Jung A. Kim. (2018) Factor analysis of the Zarit Burden Interview in family caregivers of patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:1-2, pages 50-56.
Read now
Fabio Coppedè, Andrea Stoccoro, Lorena Mosca, Roberta Gallo, Claudia Tarlarini, Christian Lunetta, Alessandro Marocchi, Lucia Migliore & Silvana Penco. (2018) Increase in DNA methylation in patients with amyotrophic lateral sclerosis carriers of not fully penetrant SOD1 mutations. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:1-2, pages 93-101.
Read now
Xinglong Yang, Shimei Li, Dongmei Xing, Peiyun Li, Ci Li, Ling Qi, Yanming Xu & Hui Ren. (2018) Lack of association between the P413L variant of chromogranin B and ALS risk or age at onset: a meta-analysis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:1-2, pages 80-86.
Read now
. (2017) Open-label 24-week extension study of edaravone (MCI-186) in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:sup1, pages 55-63.
Read now
Robert G. Miller & Stanley H. Appel. (2017) Introduction to supplement: the current status of treatment for ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:sup1, pages 1-4.
Read now
Koji Takei, Kikumi Tsuda, Fumihiro Takahashi, Manabu Hirai & Joseph Palumbo. (2017) An assessment of treatment guidelines, clinical practices, demographics, and progression of disease among patients with amyotrophic lateral sclerosis in Japan, the United States, and Europe. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:sup1, pages 88-97.
Read now
Koji Takei, Kazutoshi Watanabe, Satoshi Yuki, Makoto Akimoto, Takeshi Sakata & Joseph Palumbo. (2017) Edaravone and its clinical development for amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:sup1, pages 5-10.
Read now
Andrew M. Geronimo & Zachary Simmons. (2017) The P300 ‘face’ speller is resistant to cognitive decline in ALS. Brain-Computer Interfaces 4:4, pages 225-235.
Read now
Irina Enache, Cristina Pistea, Marie Fleury, Mickael Schaeffer, Monique Oswald-Mammosser, Andoni Echaniz-Laguna, Christine Tranchant, Nicolas Meyer & Anne Charloux. (2017) Ability of pulmonary function decline to predict death in amyotrophic lateral sclerosis patients. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:7-8, pages 511-518.
Read now
Andrew Geronimo, Courtney Wright, Anne Morris, Susan Walsh, Bethany Snyder & Zachary Simmons. (2017) Incorporation of telehealth into a multidisciplinary ALS Clinic: feasibility and acceptability. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:7-8, pages 555-561.
Read now
Cristina Moglia, Andrea Calvo, Antonio Canosa, Davide Bertuzzo, Paolo Cugnasco, Luca Solero, Maurizio Grassano, Enrica Bersano, Stefania Cammarosano, Umberto Manera, Fabrizio Pisano, Letizia Mazzini, Laura A. Dalla Vecchia, Gabriele Mora & Adriano Chiò. (2017) Influence of arterial hypertension, type 2 diabetes and cardiovascular risk factors on ALS outcome: a population-based study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:7-8, pages 590-597.
Read now
Jesús Sancho, Emilio Servera, Pilar Bañuls & Julio Marín. (2017) Effectiveness of assisted and unassisted cough capacity in amyotrophic lateral sclerosis patients. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:7-8, pages 498-504.
Read now
Ashley Crook, Kelly Williams, Lorel Adams, Ian Blair & Dominic B. Rowe. (2017) Predictive genetic testing for amyotrophic lateral sclerosis and frontotemporal dementia: genetic counselling considerations. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:7-8, pages 475-485.
Read now
Taha Omer, Eoin Finegan, Siobhan Hutchinson, Mark Doherty, Alice Vajda, Russell L. McLaughlin, Niall Pender, Orla Hardiman & Peter Bede. (2017) Neuroimaging patterns along the ALS-FTD spectrum: a multiparametric imaging study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:7-8, pages 611-623.
Read now
Sylvie Lavernhe, Jean-Christophe Antoine, Isabelle Court-Fortune, Nathalie Dimier, Frédéric Costes, Arnaud Lacour & Jean-Philippe Camdessanché. (2017) Home care organization impacts patient management and survival in ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:7-8, pages 562-568.
Read now
Piero Ceriana, Sara Surbone, Daniele Segagni, Annia Schreiber & Annalisa Carlucci. (2017) Decision-making for tracheostomy in amyotrophic lateral sclerosis (ALS): a retrospective study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:7-8, pages 492-497.
Read now
Zara A. Ioannides, Frederik J. Steyn, Robert D. Henderson, Pamela A. Mccombe & Shyuan T. Ngo. (2017) Anthropometric measures are not accurate predictors of fat mass in ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:7-8, pages 486-491.
Read now
Peggy Barschke, Patrick Oeckl, Petra Steinacker, Albert Ludolph & Markus Otto. (2017) Proteomic studies in the discovery of cerebrospinal fluid biomarkers for amyotrophic lateral sclerosis. Expert Review of Proteomics 14:9, pages 769-777.
Read now
Elena Cortés-Vicente, Jesús Pradas, Juan Marín-lahoz, Noemi De Luna, Jordi Clarimón, Janina Turon-Sans, Ellen Gelpí, Jordi Díaz-Manera, Isabel Illa & Ricard Rojas-Garcia. (2017) Early diagnosis of amyotrophic lateral sclerosis mimic syndromes: pros and cons of current clinical diagnostic criteria. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:5-6, pages 333-340.
Read now
Gabriella Santangelo, Mattia Siciliano, Luigi Trojano, Cinzia Femiano, Maria Rosaria Monsurrò, Gioacchino Tedeschi & Francesca Trojsi. (2017) Apathy in amyotrophic lateral sclerosis: insights from Dimensional Apathy Scale. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:5-6, pages 434-442.
Read now
Kristen M. Allison, Yana Yunusova, Thomas F. Campbell, Jun Wang, James D. Berry & Jordan R. Green. (2017) The diagnostic utility of patient-report and speech-language pathologists’ ratings for detecting the early onset of bulbar symptoms due to ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:5-6, pages 358-366.
Read now
Wendeline Reniers, Maarten Schrooten, Kristl G. Claeys, Petra Tilkin, Ann D’Hondt, Dimphna Van Reijen, Goedele Couwelier, Nikita Lamaire, Wim Robberecht, Steffen Fieuws & Philip Van Damme. (2017) Prognostic value of clinical and electrodiagnostic parameters at time of diagnosis in patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:5-6, pages 341-350.
Read now
Yu-ichi Noto, Neil Simon, Kazumoto Shibuya, José M. Matamala, Thanuja Dharmadasa & Matthew C. Kiernan. (2017) Dynamic muscle ultrasound identifies upper motor neuron involvement in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:5-6, pages 404-410.
Read now
Fabrizio D’Ovidio, James P. K. Rooney, Anne E. Visser, Roel C. H. Vermeulen, Jan H. Veldink, Leonard H. Van Den Berg, Orla Hardiman, Giancarlo Logroscino, Adriano Chiò & Ettore Beghi. (2017) Critical issues in ALS case-control studies: the case of the Euro-MOTOR study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:5-6, pages 411-418.
Read now
Mattia Siciliano, Gabriella Santangelo, Francesca Trojsi, Carmela Di Somma, Manila Patrone, Cinzia Femiano, Maria Rosaria Monsurrò, Luigi Trojano & Gioacchino Tedeschi. (2017) Coping strategies and psychological distress in caregivers of patients with Amyotrophic Lateral Sclerosis (ALS). Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:5-6, pages 367-377.
Read now
P. A. McCombe, N. R. Wray & R. D. Henderson. (2017) Extra-motor abnormalities in amyotrophic lateral sclerosis: another layer of heterogeneity. Expert Review of Neurotherapeutics 17:6, pages 561-577.
Read now
Sophie Claire Andrews, Alexia Pavlis, Mathew Staios & Fiona Fisher. (2017) Which behaviours? Identifying the most common and burdensome behaviour changes in amyotrophic lateral sclerosis. Psychology, Health & Medicine 22:4, pages 483-492.
Read now
Christian Burkhardt, Christoph Neuwirth & Markus Weber. (2017) Longitudinal assessment of the Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen (ECAS): lack of practice effect in ALS patients?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:3-4, pages 202-209.
Read now
Marina Tesauro, Michela Consonni, Tommaso Filippini, Letizia Mazzini, Fabrizio Pisano, Adriano Chiò, Aniello Esposito & Marco Vinceti. (2017) Incidence of amyotrophic lateral sclerosis in the province of Novara, Italy, and possible role of environmental pollution. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:3-4, pages 284-290.
Read now

Displaying 200 of 3792 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.